Literature DB >> 3533681

Insulin dose-response characteristics for suppression of glycerol release and conversion to glucose in humans.

N Nurjhan, P J Campbell, F P Kennedy, J M Miles, J E Gerich.   

Abstract

To compare the dose-response characteristics for suppression of lipolysis and suppression of glucose production by insulin, 13 normal nonobese individuals were infused with insulin at rates of 0.1, 0.2, 0.4, 0.8, and 1.6 mU X kg-1 X min-1 while normoglycemia was maintained with the glucose clamp technique. Glucose appearance and glycerol appearance (taken as index of lipolysis) were measured isotopically with simultaneous infusions of 3-[3H]glucose and U-[14C]glycerol. Baseline glucose and glycerol rates of appearance were 14 +/- 0.5 and 1.7 +/- 0.2 mumol X kg-1 X min-1, respectively. Approximately 3% of plasma glucose originated from glycerol, and this accounted for approximately 50% of glycerol disposal. During the insulin infusions, arterial insulin (basal, 9.8 +/- 0.6 microU/ml) increased to 14 +/- 0.5, 20 +/- 0.5, 31 +/- 1, 58 +/- 2, and 104 +/- 6 microU/ml; calculated portal venous insulin (basal, 24 +/- 2 microU/ml) increased to 26 +/- 1, 32 +/- 3, 70 +/- 4, and 115 +/- 6 microU/ml. The rate of glucose appearance was suppressed 100%, whereas the rate of appearance of glycerol was maximally suppressed only 85%. Nevertheless, the insulin concentration that produced half-maximal suppression of glucose appearance was twice as great as that required for half-maximal suppression of glycerol appearance (26 +/- 2 vs. 13 +/- 2 microU/ml, P less than .001). Insulin decreased both the absolute rate of glycerol conversion to plasma glucose and the percent of glycerol disposal appearing in plasma glucose (both P less than .001).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3533681     DOI: 10.2337/diab.35.12.1326

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  36 in total

1.  Phenylalanine kinetics in human adipose tissue.

Authors:  S W Coppack; M Persson; J M Miles
Journal:  J Clin Invest       Date:  1996-08-01       Impact factor: 14.808

2.  Glucocorticoid-Induced Metabolic Disturbances Are Exacerbated in Obese Male Mice.

Authors:  Innocence Harvey; Erin J Stephenson; JeAnna R Redd; Quynh T Tran; Irit Hochberg; Nathan Qi; Dave Bridges
Journal:  Endocrinology       Date:  2018-06-01       Impact factor: 4.736

3.  Hydroxysteroid 17-β dehydrogenase 13 variant increases phospholipids and protects against fibrosis in nonalcoholic fatty liver disease.

Authors:  Panu K Luukkonen; Taru Tukiainen; Anne Juuti; Henna Sammalkorpi; P A Nidhina Haridas; Onni Niemelä; Johanna Arola; Marju Orho-Melander; Antti Hakkarainen; Petri T Kovanen; Om Dwivedi; Leif Groop; Leanne Hodson; Amalia Gastaldelli; Tuulia Hyötyläinen; Matej Orešič; Hannele Yki-Järvinen
Journal:  JCI Insight       Date:  2020-03-12

4.  Increased lipolysis and its consequences on gluconeogenesis in non-insulin-dependent diabetes mellitus.

Authors:  N Nurjhan; A Consoli; J Gerich
Journal:  J Clin Invest       Date:  1992-01       Impact factor: 14.808

5.  Causal linkage between insulin suppression of lipolysis and suppression of liver glucose output in dogs.

Authors:  K Rebrin; G M Steil; S D Mittelman; R N Bergman
Journal:  J Clin Invest       Date:  1996-08-01       Impact factor: 14.808

Review 6.  Metabolic Flexibility in Health and Disease.

Authors:  Bret H Goodpaster; Lauren M Sparks
Journal:  Cell Metab       Date:  2017-05-02       Impact factor: 27.287

7.  Role of insulin resistance in decreasing lipoprotein lipase activity in tumor-bearing rats.

Authors:  Y Noguchi; K Nomura; T Yoshikawa; K Fukuzawa; T Makino; A Tsuburaya; A Matsumoto
Journal:  Surg Today       Date:  1996       Impact factor: 2.549

8.  Assessment of proinsulin's effects on intermediary metabolism using the forearm technique in normal man.

Authors:  S N Davis; L Monti; P M Piatti; M Ansiferov; C Hetherington; M Brown; H Orskov; W Branch; C N Hales; K G Alberti
Journal:  Acta Diabetol       Date:  1993       Impact factor: 4.280

9.  Mechanisms of fatty acid-induced inhibition of glucose uptake.

Authors:  G Boden; X Chen; J Ruiz; J V White; L Rossetti
Journal:  J Clin Invest       Date:  1994-06       Impact factor: 14.808

10.  Determination of Krebs cycle metabolic carbon exchange in vivo and its use to estimate the individual contributions of gluconeogenesis and glycogenolysis to overall glucose output in man.

Authors:  A Consoli; F Kennedy; J Miles; J Gerich
Journal:  J Clin Invest       Date:  1987-11       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.